Mark D. Pearlman

Papers

Total Citations

H-Index

About

Mark D. Pearlman is a distinguished gynecologic surgeon and researcher whose work has significantly advanced the prevention of surgical site infections (SSIs) in gynecologic surgery. His primary research areas focus on optimizing perioperative antibiotic prophylaxis and improving surgical outcomes for women undergoing hysterectomy. Pearlman’s most impactful contribution is his landmark 2017 study, which demonstrated that combining metronidazole with cefazolin significantly reduces SSI rates compared to cephalosporin alone—a finding that has reshaped clinical guidelines and earned 54 citations. This work highlights his commitment to evidence-based practice, directly reducing patient morbidity and healthcare costs. Beyond this, Pearlman has contributed to broader discussions on surgical safety, antimicrobial stewardship, and quality improvement in gynecology. His research is widely referenced by clinicians and researchers aiming to minimize postoperative complications, making him a key figure in the field of gynecologic infectious disease. Pearlman’s dedication to translating rigorous clinical data into actionable protocols underscores his lasting impact on patient care and surgical best practices.